Sawsan As-Sanie, MD, MPH
Robert K Ferguson and Virginia A Ferguson Professor of Obstetrics and Gynecology
Professor of Obstetrics and Gynecology
Program Director and Section Head
Minimally Invasive Gynecologic Surgery Advanced Training Program
Gynecology

Available to mentor

Sawsan As-Sanie, MD, MPH
Professor
  • Center Memberships
  • Research Overview
  • Recent Publications
  • Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Research Overview

    Clinical and translational research in the epidemiology, physiology, and treatment of endometriosis and other pelvic pain disorders. I am particularly interested in elucidating the mechanisms involved in the initiation and maintenance of chronic pelvic pain and post-surgical pain, with a focus on endometriosis-associated pelvic pain.

    Recent Publications See All Publications
    • Journal Article
      Plasma proteins and persistent postsurgical pelvic pain among adolescents and young adults with endometriosis.
      Sasamoto N, Ngo L, Vitonis AF, Dillon ST, Prasad P, Laufer MR, As-Sanie S, Schrepf A, Missmer SA, Libermann TA, Terry KL. Am J Obstet Gynecol, 2024 Aug; 231 (2): 240.e1 - 240.e11. DOI:10.1016/j.ajog.2024.03.005
      PMID: 38462144
    • Journal Article
      Society of Endometriosis and Uterine Disorders forum: adenomyosis today, Paris, France, December 12, 2023.
      Catherino WH, As-Sanie S, Cozzolino M, Marcellin L, Missmer SA, Stewart EA, van den Bosch T, Chapron C, Petraglia F. F S Sci, 2024 Aug; 5 (3): 265 - 271. DOI:10.1016/j.xfss.2024.06.006
      PMID: 38945479
    • Journal Article
      The Burden of Pelvic Pain Associated With Endometriosis Among Women in Selected European Countries and the United States: A Restricted Systematic Review.
      As-Sanie S, Shafrir AL, Halvorson L, Chawla R, Hughes R, Merz M. J Minim Invasive Gynecol, 2024 Aug; 31 (8): 653 - 666.e5. DOI:10.1016/j.jmig.2024.05.002
      PMID: 38729420
    • Proceeding / Abstract / Poster
      Relugolix combination therapy vs relugolix monotherapy with transition to relugolix combination therapy for the treatment of endometriosis-associated pain: implications for cumulative benefit/risk profile
      Becker C, As-Sanie S, Zhai D, Perry JS, Dynowski K, Wilk K, Wagman RB, Rakov VG, McClung MR. Human Reproduction, 2024 Jul 3; 39 (Supplement_1): deae108.273 - deae108.273. DOI:10.1093/humrep/deae108.273
    • Journal Article
      From Dismissal to Solutions: Prioritizing Scientific Discovery and Patient-Centered Care in Chronic Pelvic Pain.
      As-Sanie S. Obstet Gynecol, 2024 Jul 1; 144 (1): 1 - 3. DOI:10.1097/AOG.0000000000005639
      PMID: 38949540
    • Journal Article
      Two-year efficacy and safety of relugolix combination therapy in women with endometriosis-associated pain: SPIRIT open-label extension study.
      Becker CM, Johnson NP, As-Sanie S, Arjona Ferreira JC, Abrao MS, Wilk K, Imm SJ, Mathur V, Perry JS, Wagman RB, Giudice LC. Hum Reprod, 2024 Mar 1; 39 (3): 526 - 537. DOI:10.1093/humrep/dead263
      PMID: 38243752
    • Journal Article
      Effect of Best Practice Alert (BPA) on Post-Discharge Opioid Prescribing After Minimally Invasive Hysterectomy: A Quality Improvement Study.
      Jankulov A, As-Sanie S, Zimmerman C, Virzi J, Srinivasan S, Choe HM, Brummett CM. J Pain Res, 2024 17: 667 - 675. DOI:10.2147/JPR.S432262
      PMID: 38375407
    • Journal Article
      Impact of relugolix combination therapy on functioning and quality of life in women with endometriosis-associated pain.
      As-Sanie S, Abrao MS, Reznichenko G, Wilk K, Zhong Y, Perry J, Hunsche E, Soulban G, Becker CM. Fertil Steril, 2024 Jun 19; DOI:10.1016/j.fertnstert.2024.06.009
      PMID: 38906210
    Featured News & Stories Fall 2023 WHIF Winners
    Department News
    2023 Women's Health Innovation Fund Award Recipients
    Award recipients are advancing innovative research that has the potential to transform women's health.